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Abstract 
The self-assembly of specific polymers into well-defined nanoparticles (NPs) is of great interest 
to the pharmaceutical industry as the resultant materials can act as drug delivery vehicles. In 
this work a high-throughput method to screen the ability of polymers to self-assemble into 
nanoparticles (NPs) using a picoliter ink-jet printer is presented. By dispensing polymer 
solutions in DMSO from the printer into the wells of a 96-well plate, containing water as an 
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antisolvent, we screened 50 suspensions for nanoparticle formation rapidly using only nanoliter 
to microliter. A variety of polymer classes were used, and in situ characterization of the sub-
microliter nanosuspensions showed that the particle size distributions matched those of 
nanoparticles made from bulk suspensions. Dispensing organic polymer solutions into well-
plates via the printer was thus shown to be a reproducible and fast method for screening 
nanoparticle formation which uses two to three orders of magnitude less material than 
conventional techniques. 
Finally, a pilot study for a high-throughput pipeline of nanoparticle production, physical 
property characterization and cytocompatibility demonstrated the feasibility of the printing 
approach for screening of nano-drug delivery formulations. Nanoparticles were produced in the 
well plates, characterised for size and evaluated for effects on metabolic activity of lung cancer 
cells. 
 
1. Introduction 
Over the last few decades, the application of nanotechnologies to the biomedical and 
pharmaceutical field has significantly enhanced global health, improving diagnosis and 
treatment of several diseases.[1],[2] A plethora of different materials has been used to produce 
nanosized carriers, from biodegradable polymers and lipids up to inorganic materials, and to 
date 51 nanoparticle (NP) formulations have been approved by the FDA for clinical applications 
(e.g. Neulasta, Copaxone[3]). However, NP formulations can be challenging as there is a 
constant need to establish both functional and novel chemical and technological approaches in 
order to i) optimize the self-assembly behaviour of the base materials into NPs; ii) control and 
establish the reproducibility of the size, shape and colloidal behaviour of the NPs in accordance 
to the needs of the biomedical application; iii) modulate the encapsulation and the release rate 
of well-defined drugs and iv) minimise the use of surfactants and organic solvents in the 
preparation process. To address some of these needs, much interest has been focused on 
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amphiphilic block copolymers due to their versatility, their tunable properties and their ability 
to self-assemble into various types of NPs (micelles, nanospheres, nanocapsules and 
polymersomes).[4],[5],[6]  A range of different preparation techniques can be used, with typical 
polymeric NP preparation techniques involving in situ precipitation and solvent displacement, 
where the polymeric NPs self-assemble in the presence of a solvent (usually water), which is 
unfavourable for one block of the amphiphilic polymer. Such methods reduce the need of 
surfactants in the formulation process and utilise water-miscible solvents that can be easily 
removed if required. 
Nevertheless, conventional methods need materials in the milligram scale, require days for the 
full removal of the solvent, face issues with scalability and batch-to-batch variability and 
frequently result in NPs with wide size distributions. Employing more sophisticated 
technologies to test new materials in an easy, fast and automated way that will enable the 
modulation of the NPs properties is still an unresolved challenge in this field. In this context, 
there is a real need for high throughput technologies to screen rapidly a large number of 
materials and optimise their formulation conditions. For example, the use of inkjet technology 
to obtain polymeric microspheres with defined sizes,[7] protein encapsulated polymeric micro-
structures [8] and loaded drug-polymer micro-particles[9] has been well established in the 
literature. On this basis, inkjet printing could potentially be a promising alternative to the 
conventional methods used for the production of NPs. Inkjet printing is a versatile, scalable and 
relatively inexpensive method of depositing small volumes of solutions, even down to the 
picoliter range, with remarkable accuracy and reproducibility. As inkjet printers become more 
commercially available, their use in the field of drug delivery has increased. 
Different materials have been printed by inkjet systems spanning from cells,[10] to genes[11],[12] 
or proteins[13] to polymers[14] to nanomaterials and some pharmaceutical formulations.[15],[16],[17]  
In a singular and pioneering work by Hauschild et. al, [15]  unilamellar nano-vesicles were 
printed from a conventional desktop inkjet printer, using ethanol solutions of both lipid-like and 
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amphiphilic copolymers, resulting in NPs with reproducible sizes ranging between 50 and 220 
nm. In the same work, it was also shown that fluorescein loaded vesicles with narrow-size 
distributions could be directly produced via the printing method. [15] However, in the literature, 
preparation of these NPs with the use of a conventional desk-top inkjet printer required solution 
volumes at the scale of 1 mL, similar to the ones needed for conventional individual batches 
prepared manually. While Hauschild et.al suggested that the inkjet NP-fabrication method 
would be relatively easy to integrate within a high-throughput platform, no reports to date exist 
in which ink-jet printing has been adopted to rapidly screen polymers able to self-assemble in 
water by using nano-to-micrograms of materials. 
Therefore, in the present work we show a high-throughput, fast, reproducible and automated 
method to screen the self-assembling properties of different polymers into nanoparticles. The 
screening is accomplished via a 2-D picolitre-capable ink-jet printer dispensing polymer 
solutions into an anti-solvent (water) by using few microgram of final materials, contained in a 
96-well plate system. We have employed a wide range of readily available commercial 
polymers, as well as some customised polymers from our own laboratories. Polymers with 
different architectures, linear block copolymers and grafted copolymers (polymer properties 
described in Table 1), were screened by using only micro-amounts/volumes (for a final NP 
concentration of 500 µg/mL only 100 µg of polymer was required in 10 µL of DMSO dispensed 
in around 10 s in 200 µL of water) to evaluate their ability to self-assemble and to measure their 
size in different concentrations. All the concentrations were chosen based on previously 
published methods shown to allow polymer chains to self-assemble in water, and the data for 
these polymers were compared against appropriate control materials.[18],[19] 
The versatility of the ink-jet printing technology presented here as a miniaturized screening 
method may have implications for multiple pharmaceutics platforms.  
In this regards, Giardiello et al.[20] developed an accelerated nanomedicine platform to generate 
a potential aqueous paediatric HIV nanotherapy, targeting oral dose, with clinical translation 
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and regulatory approval for human evaluation. Giardiello’s small-scale screening used 1 mg of 
drug compound, generating large libraries of solid drug nanoparticles (160 individual 
components), and iterative pharmacological and chemical evaluation established potential 
candidates for progression through to clinical manufacture. The inkjet NP-fabrication method 
of the present work might be employed as a miniaturized pre-formulation screening step to be 
integrated within the work of Giardiello reported above or within general accelerated 
nanomedicine platform approaches where nanodispersions are screened as a valuable 
alternative to molecular solutions.[21] 
Finally, as a case study for a high throughput pipeline for nanoparticle production, 
characterization and effects on cell metabolic activity, a small experiment with selected 
polymers was performed. This proof-of-concept ‘on-line assay’ demonstrated the feasibility of 
the printing approach to screen formulations, from nano-particle preparation to preliminary 
cytotoxicity assays in a high-throughput fashion.  
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2. Results and Discussion 
 
2.1 Validation of the use of ink-jet printing as a miniaturized methodology to screen 
polymers self-assembling in water by means of traditional analysis. 
2.1.1 Known block-copolymer structures (mPEG-b-PCL, mPEG-b-PLGA and mPEG-b-PeDL) 
Block co-polymers widely used in the drug delivery field such as mPEG-b-PCL and mPEG-b-
PLGA,[22],[23],[24] well-known to self-assemble in water into NPs, were first used to test the 
usefulness of the ink-jet printer as a NP formation screening technique. mPEG-b-PCL and 
mPEG-b-PLGA (50/50) were initially analysed at one single concentration (Figure 1a). 
Subsequently, to evaluate the reproducibility of the printer, replicates of mPEG-b-PLGA 
(50/50) were dispensed at different concentrations (Figure 1-c and SI). Moreover, a third block 
copolymer, mPEG-b-PɛDL, with the hydrophobic part derived from renewable sources,[25,26] 
thus, a convenient “green” replacement for PCL, was dispensed at two different concentrations 
in duplicate during the first set of experiments. Consistent reproducibility of mPEG-b-PLGA 
samples in terms of size distribution was observed and a similar trend with the common 
individual manual NP sample preparation method was also was observed (SI, Tables 1 and 2 
for the reproducibility experiments).  
Contrary to some typical nanoparticle preparation protocols, where the nanoparticle suspension 
is filtered for the removal of any aggregates, we did not filter the solutions containing the 
fabricated nanoparticles prior to the analysis, due to the small amount of suspension produced 
in the 96-well plate system. Thus, at the stage of the light scattering measurements, formation 
of precipitates during the measurements were noted (see correlograms and intensity 
distributions in SI, SI-Figure 3 and SI-Figure 4). Further manual/conventional experiments 
were performed, neglecting the filtration step, in order to investigate the ability of our method 
to mimic any events occurring at the larger mg scale. Consistently, aggregates were observed 
also in this latter conventional way to produce NPs (Figure 1d). In order to probe better these 
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common outcomes, a comparison with literature of similar polymeric structures in terms of 
chemistry and NP formation technique was established. In previously published work,[19] ,[27] 
the ability of mPEG-b -PCL and PEG-b-PɛDL to self-assemble and produce micelles was tested 
by dissolving the copolymers in acetone and adding the organic solutions at a fixed rate into 
HPLC grade water by using a pump system (each set of experiments involved 50 mg of 
polymer). Once the acetone was removed by slow evaporation under constant stirring, the 
micellar nano-suspensions were subsequently filtered through a membrane syringe filter (pore 
size: 220 nm) (Millex-LG, Millipore Co., USA) in order to remove aggregates and impurities 
formed during the self-assembling mechanism.[19],[28],[29] We found possible formation of 
aggregates of similar materials by the printed method as well, where just a few µg were used 
instead of the 50 mg used in the existing literature. 
 
 
 
2.1.2 PGA and its derivatives tested and compared to manual experiments  
Further investigations were performed using Poly(glycerol-adipate) (PGA)[30],[31] and some of 
its modifications (Figure 2a) as a polymeric platform. PGA is an amphiphilic polymer, which 
can be enzymatically synthesised from divinyl adipate and glycerol, with a tunable amount of 
branches along the main backbone.[30] Due to its intrinsically non-toxic amphiphilic nature, this 
kind of polyester has been further functionalized to engineer new polymeric platforms for 
nanotechnology in the healthcare field. In particular, it has been further modified with 
biological molecules such as fatty acids and amino acids in order to enhance drug protein or 
nucleic acids interactions or encapsulation, or simply to tailor its hydrophobic-hydrophilic 
balance.[30],[31],[32] PGA derivatives, including the bare polymer, showed molecular weights in 
the order of 20000 Da and all the materials were found to present an amorphous behaviour with 
Tg transitions ranging from -33 to 49 °C (see also Table 1).
[18] Full characterisation of these 
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polymers has been published in the past[18] and for this reason is not included in this present 
work.  
Unmodified and amino-acid modified (N-acylated Phenylalanine and N-acylated Tryptophan) 
PGAs, dispensed in various concentrations, formed well defined nanoparticles with 
hydrodynamic diameters in the range of 50 nm to 150 nm (Figure 2b). The diameter of the 
particles fabricated by the printer showed a similar trend to those prepared by the traditional 
manual method (Table 2) although some variance in final size values can be appreciated. These 
alterations may be attributed to several variables such as the lack of stirring in the printing step, 
the different rate of addition of the polymeric solution in water and the relative kinetics of 
solvent mixing. All the modified PGA adopted in the present work had 50% mol/mol average 
ratio of functionalisation.  
PGA-Phe and PGA-Trp were also re-printed thrice to estimate the reproducibility of the 
methodology with these grafted polymers. As can be seen from Figure 3 and Table 2 both sizes 
and PDIs were consistent by the DLS measurements.  
In the attempt to assess the shape of some printed NPs in the dry state, we used TEM imaging. 
DLS allows the evaluation of the solvated NPs’ size, where the values reported correspond to 
the NPs hydrodynamic diameter and as such are affected by solvent molecules associated to the 
nanomaterials, while TEM facilitates measurement of the dry and thus more compacted state 
of the nanoparticles.  
PGA Trp (54±11 nm, SI-Figure 16a) and PGA Phe NPs (77±18 nm, SI-Figure 16b) showed a 
distribution of circular shaped NPs by TEM. As expected the dry diameter sizes are different 
from the ones recorded by DLS (PGA Trp 64±1 nm and PGA Phe 133±1 nm). It can also be 
seen that some of the particles do not show a well-defined spherical shape. We speculate that 
this effect is due to the partial evaporation of DMSO from the TEM specimen due to lack of 
further treatment, such as dialysis, as in common NPs formulation approaches. Nevertheless, 
TEM pictures showed a similar trend of DLS in final particles sizes behaviour, where PGA Trp 
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NPs were smaller than PGA Phe NPs and provided a promising first insight into the adoption 
of the printing methodology as a screening technique for pre-formulation steps. These size 
differences between these two techniques are large but consistent and it is a phenomenon that 
is well established and reported.[33] 
 
 
2.1.3 Large scale batch experiments  
To further validate the printing screening approach, a larger scale batch experiment was 
performed. PGA was employed as a model system in the fabrication of 60 samples at two 
different concentrations (50 and 100 µg/mL) in one single printing event that required less than 
20 minutes to be completed. All the samples were contained in a single well-plate and sizes 
were measured directly in a DLS plate-reader. It can be observed from SI-Figure 17 that the 
printing batch-screening showed a good reproducibility in terms of sizes and particle 
distributions at the two explored concentrations. Interestingly, despite the similarity in 
concentration values, it is possible to evaluate differences in sizes with a marginal deviation 
between the two values, 71±4 nm for the 100 µg/mL and 65±2 for the 50 µg/mL. This additional 
experiment may confirm the use of a printer to direct the self-assembling of amphiphilic 
materials in a large scale, such as for industrial batch-screening.  
 
 
 
2.1.4 Negative printing controls and validation of method 
Negative “printing” controls were also performed using polymers that were not expected to 
self-assemble once dispensed in water without the use of a second surfactant,[34],[35] PVP and 
PVPVA demonstrated very poor correlation on the DLS (Figure 4). These latter sets of 
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observations highlight the possibility to distinguish between materials able to self-assemble in 
water and those which do not self-assemble, thus avoiding any “false-positive” results.  
 
 
2.2 Case study scenario: NPs production, self-assembling screening and biological 
response of selected polymeric materials in high-throughput fashion.  
A pilot study investigating a high throughput pipeline of printed nanoparticle production, 
characterization and cell-based screening was performed. The above experiments were repeated 
on a small scale in an entirely high-throughput fashion, with the intention that this process may 
be translated as an example to validate the use of polymers as a carrier for drug delivery 
formulations. Five samples were chosen for the study: three PGA variants (namely PGA, PGA 
Phe and PGA Trp) as well as two negative control polymers (PVP and PVPVA) that previously 
were found not to self-assemble. All the materials were printed in a well-plate containing water 
at two different concentrations (50 and 250 µg/mL) and were directly analysed for their self-
assembling ability by a high throughput DLS plate reader (HT-DLS). To corroborate the 
concept of pipeline screening a high throughput cell cytotoxicity assay (MTS) was carried out 
directly on the printed samples without any further or intermediate purifications. 
The HT-DLS data of the printed versus the samples prepared in bulk revealed a similarity in 
the sizes obtained for all the PGA variant polymers was noticed (Figure 5 see also SI-Figure 
18). Two trends were observed for both the NP preparation techniques adopted. Both PGA-Phe 
and PGA-Trp at the two explored concentrations showed sizes bigger than pure PGA NPs. At 
the same time, a clear enlargement of NPs sizes for all the explored materials was observed on 
increasing the concentration from 50 µg/mL to 250 µg/mL.  
Cytotoxicity is of critical importance for the clinical translation of any kind of nanosized carrier. 
The formulation strategies employed for NPs production, including the presence of surfactants 
and of course of solvent traces, significantly affect cell metabolism. In our formulations, the 
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concentration of DMSO in the final nanosuspensions was determined to be non-cytotoxic 
(Figure 6), in agreement with previous evidence.[36] In fact, as evident in Figure 6, the different 
NP formulations obtained by printing, did not show any negative effects on the metabolic 
activity of H1299 lung cancer cells after 24h of treatment, in line with the data reported for NPs 
made by similar polymers but through different formulation processes.[36] Therefore, the high 
throughput method of directly transferring the formulations in the well plates to any cell-based 
assays required, including cytotoxicity assays, has been validated. It should be noted that 
previous literature has shown that PGA and its derivatives are not toxic (although different cell 
lines have been used in previous works).[18],[31],[37] 
Taking this into consideration, the successful in vitro application of different polymers reported 
throughout the present manuscript was validated. The polymers selected had different structures, 
molecular weight distributions and amphiphilic properties. Both size measurement distributions 
and repeat sequences of negative controls showed an excellent match with manually-prepared 
nanosuspensions. At the same time, the precision of the system allowed the fast and accurate 
calculation of the number of droplets needed to achieve the final polymer concentrations. The 
suitability and versatility of the technology presented here as a miniaturized screening method 
may have implications for multiple pharma and medical platforms.  
 
 
 
 
3. Conclusions 
The results presented support the adoption of inkjet printing as a high throughput NP 
formulation investigation method, with the key strengths of the method lying in the automation, 
low amounts used, and reproducibility. To probe the self-assembling behaviour of any of the 
materials tested in the present work at the final concentration of 1 mg/mL (in triplicate), a total 
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of 600 µg of polymer was required. This could be dispensed in a few minutes without any 
human intervention (see Calculation sheet). The rapid addition of small amounts of polymer-
DMSO solution allowed the quick diffusion of the DMSO without the need for mechanical 
stirring and thus the controlled formation of the NPs.  
Known block copolymers such as mPEG-b-PCL and mPEG-b-PLGA were initially used, as 
models, to explore the ability of an ink-jet printer to produce NPs inside a well-plate. The 
printed NPs showed good reproducibility throughout the sample polymer set and a close match 
with the particles prepared manually. Interestingly, although a limited amount of material was 
used, it was possible to link aggregate formation with the mg scale samples formed by the 
conventional method, which is consistent with evidence of aggregation previously reported in 
literature. By adopting the same nozzle/instrument conformation it is also possible to use 
solvents such as water, DMF, DMSO and mixtures with low boiling point solvents.  However, 
for the scope of screening the self-assembling of materials mimicking a nanoprecipitation 
process, there are two key advantages in the selection of DMSO as solvent. DMSO is water 
miscible, allowing the nanoparticle formation via solvent displacement to take place, and 
DMSO has a high boiling point to avoid nozzle clogging. DMSO is also the most common 
solvent used in the drug discovery field to dissolve, screen and store the thousands of 
compounds synthesized and designed by combinatorial chemistry.[38] Additionally, the 
adoption of the ink-jet printer to probe the ability of polymer chains to self-assemble in NPs 
showed remarkable advantages, including the use of limited amounts of materials, full 
automation, low amount of waste, reduction of toxic solvents, fast screening and miniaturized 
storage. In fact, taking into account this latter variable, all the printed samples explored in the 
present work (over 100, considering all the replicates) were stored in a couple of 96 well-plates 
while the same samples prepared manually needed to be stored in as many vials as number of 
wells to match the full comparison. Not only, the reduction of storage space renders this 
technique extremely appealing in terms of easy allocation and sample/data retrieval. Even on 
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the repeat printing sequences of the negative controls (PVP and PVPVA) the results were 
completely reproducible.  
Finally, a pilot study of high throughput pipeline of nanoparticle production, characterization 
and cell assay demonstrated the feasibility of the printing approach for screening of nanodrug 
delivery formulations. We believe the high throughput self-assembly characterisation via 2D 
inkjet printing has the potential to become a standard method for particle engineering and rapid 
formulation development.  
 
 
4. Experimental Section  
4.1 Printing set-up and work flow conditions  
Prior to dispensing the DMSO polymer solution into a 96-well plate filled with antisolvent 
(water, 200 µL per well), the target had to be programmatically defined. Firstly, the outer 
dimensions of the plate were added to the software sciFLEXARRAYER (Scienion AG, version 
2.09.002) followed by defining the number of wells, well distance, well depth and the spot area 
(area within the target designated for spotting). Within the spot area, a field pattern was defined 
as a 9x9 spot matrix. After setting up the field pattern, the field setup was used to address the 
wells from the probe substrate to the spots. The probe substrate consists of the well plate 
containing the polymer solution with a starting concentration of 10 mg/mL (Scheme 1(A)). 
DMSO polymer solutions were dispensed via a piezo electric inkjet printer (Sciflexarray S5, 
Scienion) using a 90 µm orifice nozzle. The nozzle was programmed to dispense the DMSO 
polymer solutions into the well from a vertical distance of circa 10-20 mm from the well-plate, 
without touching the water surface.   In all experiments, 25 spots in the defined field (Scheme 
1 B, highlighted in light green) were selected as the “print pattern”. The droplet size was 
controlled by the values of the voltage and electrical pulse. The voltage and electrical pulse 
were also tuned to prevent the occurrence of satellite droplets (see Support Info, SI-Figure 1, 
SI-Figure 2). Images of the drop formation and droplet size were obtained using the printer 
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software. The final spots were imaged using the Leica MZ16 stereomicroscope. Depending on 
the concentration to be reached, the number of drops per spot was adjusted accordingly; for 
example, 1000 drops (each drop shows a volume in between 360 and 400 pL dispensed every 
30 µs) per spot for 2.0 mg/mL and 3 drops per spot for 0.001 mg/mL. The number of drops per 
spot were selected in such a way that the volume aspired by the nozzle (max 10 µL) in the 
beginning of a run was sufficient to dispense the whole targeted final concentration of 
nanoparticles in the water volume in the well. Therefore, a multitude of runs were printed into 
the same well in order to achieve the desired polymer concentration. The amount of polymeric 
material used in the experiments is one of the strongest points of the method. In a routine 
experiment DMSO solution (10 mg/mL) droplets with nominal volumes ranging from 360 pL 
to 400 pL were dispensed into the targeted well filled with water, at a 300 Hz jetting frequency 
by adjusting the voltage and pulse between 98 V to 109 V and 53 µs to 65 µs, respectively (see 
Support Info). The nozzle was washed with DMF, in between each printing cycle, as part of the 
automated printing/washing loop. Once DMSO solutions were printed, the fast diffusion of the 
organic solvent into water drove the self-assembling of the polymers. DMSO was chosen both 
due to its high evaporation point that avoids clogging of the printer nozzle[39], because it is water 
miscible and also because it acts as a common solvent for many drugs and polymers[40],[38]. For 
the investigation of the NP formation at the highest polymer concentration of 2 mg/mL, the 
amount of polymer needed for the printing was 400 µg, while in a conventional 
nanoprecipitation this is typically up to 10 mg or more. 
 
4.2 Traditional methodology: manual preparation 
A subset of nanoparticle suspensions were prepared following a protocol previously 
established[33] (final NPs concentration equal to 2 mg/mL): 2 mL of a stock solution of polymer 
in organic solvent (DMSO, with the exception of mPEG-b-PCL where a mixture of 
DMSO:Acetone in 50:50 % vol/vol was adopted) were added dropwise to 5 mL of filtered water 
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(HPLC-grade). The solution was left overnight under constant gentle stirring for the 
evaporation of the organic solvent, when the final nanosuspension was collected for size 
analysis via DLS. This procedure required approximately 10 mg of polymer for each final 
suspension, 2 mL of DMSO, 5 mL of water and lasted approximately 24 hours. Every single 
NPs suspension needed to be stored in a vial. In comparison, the same experiment performed 
by ink-jet printing required 0.4 mg of polymer, 40 µL of DMSO and 200 µL of water. This 
latter sample was confined to one single well of a 96-well plate.  
 
4.3 Nanoparticle Size Analysis  
Dynamic Light Scattering (DLS) measurements were conducted in triplicate on the final 
unfiltered nanosuspensions, produced both manually and printed, using a Malvern Zetasizer 
Nano ZS at 25oC (scattering angle 173o, laser of 633 nm). TEM samples were prepared as 
follows; the sample in aqueous suspension (13 μL) was added to a copper grid (Formvar/Carbon 
film 200 mesh Copper (100)). The sample was left on the grid for 10 minutes and then the 
excess was removed using filter paper. Then, freshly prepared uranyl acetate (2%, 13 μL) was 
added on the grid and was left for 5 minutes before the removal of the excess with filter paper. 
The grid was allowed to dry under a fume hood for a minimum of 30 minutes prior to use. TEM 
images were captured using the FEI Biotwin-12 TEM equipped with a digital camera at the 
Nanoscale and Microscale Research Centre (NMRC) of the University of Nottingham. TEM 
image analysis for the size distribution of the NPs was performed via ImageJ (version 
1.51j8).[41] 
 
4.3.1 Particle Size Characterization using High Throughput Dynamic Light Scattering 
(HT-DLS) 
Particle size analysis of the final unfiltered nanosuspensions, produced both manually and 
printed was performed using a Wyatt DynaPro Plate Reader II DLS instrument which has a 
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laser wavelength of 817.28 nm and a scattering angle of 158°. Experimental temperature was 
set to 25 °C and auto attenuation was enabled to determine the optimal laser power and 
attenuation. For a measurement in each well containing 100 µL of sample, 10 acquisitions were 
carried out, each for 10 seconds.  DYNAMICS software implementing the Dynals algorithm 
was used for the data analysis. 
 
4.4 Metabolic activity 
H1299 lung cancer cells were obtained from the American Type Culture Collection, cultured 
at 37°C in a humidified atmosphere containing 5% CO2 and grown routinely in RPMI 
supplemented with 10% FBS, 100 unit/mL penicillin and 100 µg/mL streptomycin. H1299 cells 
were seeded at a density of 2x104 cells/well in 96 well plates and cultured in 100 µl RPMI 
medium containing 10% FBS for 24h prior to NP treatment.  NP suspensions were applied in 
culture medium at a final concentration of 125 µg/ml for 24h.   
Additionally, to study the cytocompatibility of the DMSO concentration present in the final NP 
dispersions, medium containing 0.75% (v/v) DMSO was applied to cells. Cells were also treated 
with 0.1% (v/v) Triton-X 100 and culture medium alone for 24h for use as positive and negative 
controls, respectively.  Following treatment, cells were washed with PBS and incubated with 
20 µl MTS solution (CellTiter 96® Aqueous One Solution Cell Proliferation Assay, Promega) 
diluted with 100 µl medium per well for 3h.  Absorbance was then read at 490 nm in a 
microplate reader (Tecan Spark 10M, UK).  Relative metabolic activity was calculated with the 
absorbance at 490 nm for the negative control set as 100%, and the positive control as 0%. 
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Figure 1. Hydrodynamic diameter distributions and Polydispersity indexes (PDI) of NPs 
formed from block copolymers: (a) mPEG-b-PCL and mPEG-b-PLGA NPs, formed via the 
printing method, at a final 0.5 mg/mL polymer in water concentration, (b) Cumulative graph of 
the size results of all the block copolymers used in this work in final concentrations of 0.5 
mg/mL and 1 mg/mL. With aggregation of mPEG-b-PCL at 0.5 mg/mL the 1 mg/mL 
concentration was not printed. In both (a) and (b) the error bars correspond to the standard 
deviation of the three DLS measurements. (c) Intensity based size distribution, as measured via 
DLS, for the mPEG-b-PLGA NPs, at three different final concentrations. (d) Comparison of 
the mPEG-b-PLGA NPs size distributions, as formed via the printed (straight line) and the 
traditional hand method (dotted line) at a 2 mg/mL final polymer concentration.  
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Figure 2. Investigation of forming NPs from PGA and PGA-modified polymers; (a) structures 
of the polymers, (b) comparison of sizes and PDIs between printed NPS and manually prepared 
by DLS. All the samples were prepared at 1 mg/mL as final suspension concentration in water. 
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Figure 3. Batch reproducibility of nanoparticles formed by printing PGA-Trp and PGA-Phe 
polymers. 
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Figure 4. Raw intensity and correlation data for the printed PVP and PVPVA suspensions, used 
as a negative control in this work.   
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Figure 5. High throughput DLS particle size characterisation of the final unfiltered 
nanosuspensions of Poly(glycerol-adipate) (PGA), PGA-Phenylalanine (PGA-Phe) and PGA-
tryptophan (PGA-Trp) synthesised by (A) printing and (B) manually by hand at 50 ug/mL and 
250 ug/mL polymer concentration. 
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Figure 6. Cytotoxicity for selected polymers as determined by the MTS assay.  H1299 cells 
were treated with polymers at a concentration of 125 µg/ml or with 0.75% (v/v) DMSO for 24h.  
Data are presented as relative (%) values normalized to negative control (medium alone) and 
positive control (0.1% v/v Triton-X 100), set as 100% and 0%, respectively.
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detailed view of a well with designed spot area and field, selected print pattern with adjustable 
number of drops per spot in magnified view. 
 
 
 
 
Table 1 – Table of the properties of polymers used. Molecular weight (Mn) and dispersity (Ð) 
were calculated via GPC, while thermal properties (glass transition temperature, Tg and melting 
points Tm) were assessed using DSC. 
Polymer Mn (g mol-1) Ð Tg Tm 
PGA[18] 19480 2.6 -33 - 
PGA Trp[18] 25640 2.8 49 - 
PGA Phe[18] 23980 2.2 12 - 
mPEG-b-PeDL[19] 15000 1.1 -52 57 
mPEG–b-PLGA 7900 1.3 -5 - 
mPEG-b-PCL[19] 17000 1.5 -57 60 
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Table 2. Table of the Polyglycerol adipate polymers used, both in the printed and in the 
"traditional" manual nanoprecipitation method, and resulting NP sizes as measured by dynamic 
light scattering. Average size, polydispersity index and standard deviation values were 
calculated from 3 measurements. 
Polymer 
Concentration 
(mg/ml) 
Method 
Hydrodynamic 
Diameter (nm) ± SD 
PDI ± SD 
PGA 
1 
Printed 167 ± 1  0.041 ± 0.022 
Manual 168 ± 1 0.074 ± 0.018 
0.5 
Printed 94 ± 1 0.046 ± 0.003 
Manual 105 ± 1 0.127 ± 0.018 
PGA-Trp 
1 
Printed 66 ± 1 0.091 ± 0.014 
Manual 63 ± 1 0.092 ± 0.016 
0.5 
Printed 61 ± 1 0.089 ± 0.012 
Manual 57 ± 1 0.036 ± 0.006 
PGA-Phe 
1 
Printed 132 ± 2 0.016 ± 0.006 
Manual 94 ± 1 0.087 ± 0.021 
0.5 
Printed 123 ± 2 0.018 ± 0.007 
Manual 93 ± 1 0.083 ± 0.011 
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Ink-jet printing is employed as high throughput and miniaturized method to screen 
nanoparticles (NPs) formulations. Polymer solutions are swiftly dispensed into well-plates 
using two to three orders of magnitude less material than conventional state-of-the-art 
techniques. The formation of NPs, their sizes and their cytocompatibility are directly assessed 
in a single well-plate format, minimizing human-errors and batch variability, and providing 
pilot data to assist nanoparticle selection and manufacture.   
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SI-Figure 1. Droplet Size and Printing information for the PGA, PGA Trp and PGA Phe printed 
NPs. 
 
 
 
 
 
 
  
31 
 
  
  
32 
 
 
SI-Figure 2. Droplet formation and printing information for the mPGE-PLGA, PVPVA and 
mPEG-PɛDL printed NPs. 
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SI-Table 1. Table of the diblock copolymers used, both in the printed and in the "traditional" 
manual nanoprecipitation method, and resulting NP sizes as measured by dynamic light 
scattering. Values correspond to averages of 3 measurements. 
Polymer 
Concentration 
(mg/mL) 
Method 
Hydrodynamic 
Diameter (nm) 
Pdi Figure 
mPEG-b-PeDL 
1 printed 63.25 0.055 SI-Figure 3 
0.5 printed 57.40 0.086 SI-Figure 4 
mPEG–b-PLGA 
2 
printed 200.00 0.338 
SI-Figure 5 
and in SI-
Figure 6 
manual 154.10 0.221 SI-Figure 6 
1 printed 153.30 0.326 
SI-Figure 
5Error! 
Reference 
source not 
found. 
0.5 printed 116.80 0.225 
SI-Figure 
7Error! 
Reference 
source not 
found. 
mPEG-b-PCL 
0.5 printed 366.30 0.393 SI-Figure 7 
0.25 printed 144.80 0.188  
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SI-Figure 3. PEG-PeDL NPs prepared in different batches by the printing method show 
excellent reproducibility. 
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SI-Figure 4. mPEG - PeDL printed NPs in 2 different batches, show excellent reproducibility 
of the method. 
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SI-Figure 5. mPEG-PLGA NPs prepared by printing in various concentrations 
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SI-Figure 6. mPEG-PLGA NPs prepared by printing (red) and manually (green). 
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SI-Figure 7. mPEG-b-PCL NPs formed at 0.5 mg/mL via the hand method (red line, C2) and 
via printing (green line, D2). The formation of aggregates is clear from the end shape of the 
correlogram and the same behaviour is observed visually. 
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SI-Table 2. Reproducibility of the printing method for two batches on various concentrations. 
Values correspond to averages of 3 measurements. 
Polymer 
Concentration 
(mg/mL) 
Method 
Hydrodynamic 
Diameter (nm) 
Pdi Figure 
mPEG-b-PeDL 
1 
printed 63.25 0.055 
SI-Figure 3 
printed 62.52 0.090 
0.5 
printed 57.40 0.086 
SI-Figure 4 
printed 58.09 0.071 
mPEG-b-PCL 0.5 
printed 144.80 0.188 
 
printed 280.00 0.37 
PGA 0.5 
printed 94.42 0.047 
SI-Figure 10 
printed 94.53 0.046 
PGA Trp 
1 
printed 63.43 0.116 
SI-Figure 15 
printed 66.18 0.091 
0.5 
printed 60.94 0.074 
SI-Figure 14 
printed 67.83 0.092 
PGA Phe 
1 
printed 132.30 0.016 SI-Figure 
12Error! 
Reference 
source not 
found. 
printed 134.90 0.017 
0.5 
printed 123.50 0.018 
SI-Figure 13 
printed 123.80 0.021 
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SI_Table 1. Table of the Polyglycerol adipate (PGA) and PGA modified polymers used and 
resulting NP sizes formed via the printing method, as measured by dynamic light scattering, in 
comparison with the reported literature values. Values reported via this work (printed) 
correspond to averages of 3 measurements. 
Polymer 
Concentration 
(mg/mL) 
Method 
Hydrodynamic 
Diameter (nm) 
Pdi Figure 
PGA 
2 
printed 220.10 0.059 
Error! 
Reference 
source not 
found. 
literature 108.45 0.059 - 
0.5 
Printed 94.42 0.047 
Error! 
Reference 
source not 
found. 
literature 108.00 0.100 - 
PGA Phe 0.5 
printed 123.50 0.018 
Error! 
Reference 
source not 
found. 
literature 108.10 0.015 - 
PGA Trp 0.5 
printed 60.94 0.074 
Error! 
Reference 
source not 
found. 
literature 60.51 0.042 - 
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SI-Figure 8. DLS intensity distributions of PGA NPs printed in different concentrations 
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SI-Figure 9. PGA NPs prepared at 2mg/ml manually (red) and via the printing method (green). 
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SI-Figure 10. PGA nanoparticles formed by the printing method show batch reproducibility at 
0.5 mg/mL. 
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SI-Figure 11. PGA Phenylalanine modified NPs prepared by printing in various concentrations. 
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SI-Figure 12. Phenylalanine modified NPs show excellent batch reproducibility by the printing 
method at 1 mg/mL. 
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SI-Figure 13. PGA Phenylalanine NPs printed demonstrate excellent batch reproducibility at 
0.5 mg/mL (0.25 mg/mL label is wrongly written in the data file). 
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SI-Figure 14. PGA Tryptophan modified NPs printed at different concentrations. 
 
  
  
49 
 
SI-Figure 15. PGA Tryptophan modified NPs show excellent batch reproducibility by the 
printing method at 1 mg/mL. 
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SI-Figure 16 TEM Images of PGA Trp NPs (a) (54±11 nm, N=100 particles) and PGA Phe 
modified (b) (77±18 nm, N=100). Scale bar on both is 1μm.  
(a) (b) 
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SI-Figure 17. Batch correlograms and batch size measurements of PGA nanoparticles, formed 
in a single printing experiment with 30 replicants for each concentrations, as reported via the 
High throughput DLS. 
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SI-Figure 18. Correlograms and size measurements of PGA Tryptophan nanoparticles, formed 
by printing (left) and via the traditional hand method (right), as reported via the High throughput 
DLS. 
 
